1. Home
  2. IVA vs SEAT Comparison

IVA vs SEAT Comparison

Compare IVA & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVA
  • SEAT
  • Stock Information
  • Founded
  • IVA 2011
  • SEAT 2001
  • Country
  • IVA France
  • SEAT United States
  • Employees
  • IVA N/A
  • SEAT N/A
  • Industry
  • IVA Biotechnology: Pharmaceutical Preparations
  • SEAT Industrial Machinery/Components
  • Sector
  • IVA Health Care
  • SEAT Industrials
  • Exchange
  • IVA Nasdaq
  • SEAT Nasdaq
  • Market Cap
  • IVA 359.6M
  • SEAT 366.2M
  • IPO Year
  • IVA 2020
  • SEAT N/A
  • Fundamental
  • Price
  • IVA $2.97
  • SEAT $1.70
  • Analyst Decision
  • IVA Strong Buy
  • SEAT Buy
  • Analyst Count
  • IVA 4
  • SEAT 11
  • Target Price
  • IVA $10.50
  • SEAT $4.49
  • AVG Volume (30 Days)
  • IVA 15.3K
  • SEAT 1.3M
  • Earning Date
  • IVA 09-24-2025
  • SEAT 08-05-2025
  • Dividend Yield
  • IVA N/A
  • SEAT N/A
  • EPS Growth
  • IVA N/A
  • SEAT N/A
  • EPS
  • IVA N/A
  • SEAT N/A
  • Revenue
  • IVA $14,591,573.00
  • SEAT $748,757,000.00
  • Revenue This Year
  • IVA $15.38
  • SEAT N/A
  • Revenue Next Year
  • IVA $24.22
  • SEAT $4.42
  • P/E Ratio
  • IVA N/A
  • SEAT N/A
  • Revenue Growth
  • IVA N/A
  • SEAT 0.82
  • 52 Week Low
  • IVA $1.53
  • SEAT $1.44
  • 52 Week High
  • IVA $4.05
  • SEAT $5.13
  • Technical
  • Relative Strength Index (RSI)
  • IVA 38.99
  • SEAT 44.79
  • Support Level
  • IVA $3.12
  • SEAT $1.61
  • Resistance Level
  • IVA $3.61
  • SEAT $2.06
  • Average True Range (ATR)
  • IVA 0.24
  • SEAT 0.11
  • MACD
  • IVA -0.01
  • SEAT 0.00
  • Stochastic Oscillator
  • IVA 13.95
  • SEAT 23.08

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: